Effectiveness of ChAdOx1 nCOV-19 Vaccine: Experience of a tertiary care institute

BACKGROUND: The first dose of the ChAdOx1 nCoV- 19 Corona Virus Vaccine (Covishield) was administered to the eligible beneficiaries of tertiary care institute of Western Maharashtra on 16 Jan 21 and in the past three months almost 97% of the staff has been vaccinated. The present study analyses the...

Descripción completa

Detalles Bibliográficos
Autores principales: Bobdey, Saurabh, Kaushik, S.K., Sahu, Rajesh, Naithani, Nardeep, Vaidya, Rajesh, Sharma, Mithun, Vashishtha, Kundan, Yadav, A.K., Sen, Sourav, Karade, Santosh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8313083/
https://www.ncbi.nlm.nih.gov/pubmed/34334893
http://dx.doi.org/10.1016/j.mjafi.2021.06.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8313083/
https://www.ncbi.nlm.nih.gov/pubmed/34334893
http://dx.doi.org/10.1016/j.mjafi.2021.06.006

Ejemplares similares